Zobrazeno 1 - 10 of 84 pro vyhledávání: '"M. Skrypnyk"'
1
Akademický článek
Enterprise energy supply system design management based on renewable energy sources
Autor: S. Drobyazko, M. Skrypnyk, N. Radionova, O. Hryhorevska, M. Matiukha
Publikováno v: Global Journal of Environmental Science and Management, Vol 7, Iss 3, Pp 369-382 (2021)
BACKGROUND AND OBJECTIVES: The problem of energy saving and the transition to technologies that allow to partially or completely move away from the use of gas and other fossil fuels are a priority in Ukraine today. By consuming traditional energy sou
Externí odkaz: https://doaj.org/article/ca9b1d5ea26448fc8eb1361789bb735c
Zobrazit plný text záznamu
2
Akademický článek
Chemotherapy effect on arginine / citrulline cycle indicators in patients with acute myeloid leukemia and concomitant obesity.
Autor: H. S. Maslova, I. M. Skrypnyk
Publikováno v: Medičnì Perspektivi, Vol 25, Iss 2, Pp 103-108 (2020)
The aim of study was to investigate the changes in the arginine / citrulline cycle in patients with acute myeloid leukemia (AML) with concomitant obesity in dynamics of chemotherapy (CT). The study included 20 patients with newly diagnosed AML who ha
Externí odkaz: https://doaj.org/article/f69feaafa0794ed6b22781f85b3a117d
Zobrazit plný text záznamu
3
Akademický článek
THE SYSTEMATIZATION OF METHODOLOGICAL TOOLS OF THE COST MANAGEMENT SYSTEM OF THE ENTERPRISE.
Autor: N., Radionova1 radionova_n@ukr.net, M., Skrypnyk2, M., Matiukha3, A., Sayun3, O., Bunda3
Publikováno v: Financial & Credit Activity: Problems of Theory & Practice. 2022, Vol. 2 Issue 43, p33-38. 6p.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Вплив Bifidobacterium infantis 35624 на клінічний перебіг синдрому подразненого кишечника залежно від фенотипу: результати локального неінтервенційного проспективного епідеміологічного дослідження «СПК-Контроль»
Autor: I. M. Skrypnyk, O. F. Gopko, N. P. Prykhodko, I. G. Kryvoruchko
Publikováno v: Modern Gastroenterology; № 4 (2020); 13—21
Современная гастроэнтерология; № 4 (2020); 13—21
Сучасна гастроентерологія; № 4 (2020); 13—21
Objective — to evaluate the clinical efficacy of B. infantis 35624 on the course of IBS depending on the phenotype.Materials and methods. The clinical study involved 1870 patients. From them, 1260 patients with a verified diagnosis of IBS according
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f010c4ec50d27bc75f59ca73c10dda44
https://doi.org/10.30978/mg-2020-4-13
Zobrazit plný text záznamu
6
The role of arginase and ornithine decarboxylase activity changes in the pathogenesis of liver injury in patients with acute leukemia with concomitant obesity
Autor: I. M. Skrypnyk, H. S. Maslova
Publikováno v: Bukovinian Medical Herald. 24:63-69
Стаття є фрагментом НДР кафедри внутрішньої медицини №1 Української медичної стоматологічної академії «Розробка методів профілактики
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3997678034b5fc9c998158af577cc311
https://doi.org/10.24061/2413-0737.xxiv.2.94.2020.45
Zobrazit plný text záznamu
8
IMPROVING EFFICIENCY OF ANTIOXIDANT AND CYTOPROTECTIVE THERAPY IN PATIENTS WITH NSAID-GASTROPATHY AND CONCOMITANT ISCHEMIC HEART DISEASE
Autor: V. V. Parkhomenko, I. M. Skrypnyk, A. F. Hopko
Publikováno v: Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії. 20:111-114
Introduction. Non-steroidal anti-inflammatory drugs (NSAID) are remaining to be the gold standard of antiplatelet therapy for ischemic heart disease, but at the same time NSAID therapy is associated with a number of side effects and risks, among whic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c300ba8422a1fd8e2b8775cc4b77bce9
https://doi.org/10.31718/2077-1096.20.1.111
Zobrazit plný text záznamu
9
Цитопротекторна терапія в сучасній гастроентерології: роль та місце ребаміпіду
Autor: I. M. Skrypnyk
Publikováno v: Современная гастроэнтерология; № 1 (2020); 55—61
Сучасна гастроентерологія; № 1 (2020); 55—61
Modern Gastroenterology; № 1 (2020); 55—61
The review article is devoted to the aspects of the use of cytoprotector rebamipide in the treatment and prophylaxis of digestive diseases. It stimulates production of the endogenous prostaglandins in the gastric and small intestinal mucosa, accelera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0c241a35a214796717f338bae200a3
https://doi.org/10.30978/mg-2020-1-55
Zobrazit plný text záznamu
10
Advancing the global public health agenda for NAFLD: a consensus statement
Autor: Lazarus, J.V. Mark, H.E. Anstee, Q.M. Arab, J.P. Batterham, R.L. Castera, L. Cortez-Pinto, H. Crespo, J. Cusi, K. Dirac, M.A. Francque, S. George, J. Hagström, H. Huang, T.T.-K. Ismail, M.H. Kautz, A. Sarin, S.K. Loomba, R. Miller, V. Newsome, P.N. Ninburg, M. Ocama, P. Ratziu, V. Rinella, M. Romero, D. Romero-Gómez, M. Schattenberg, J.M. Tsochatzis, E.A. Valenti, L. Wong, V.W.-S. Yilmaz, Y. Younossi, Z.M. Zelber-Sagi, S. Åberg, F. Adams, L. Khatry, M.S.A. Naamani, K.A. Murillo, O.A. Allen, A.M. Alnaser, F. Alqahtani, S.A. Alswat, K. Alvaro, D. Andrade, R.J. Arrese, M. Awuku, Y.A. Ayesha, M. Baatarkhuu, O. Bakieva, S. Basu, R. Bataller, R. Bedri, S. Bosi, E. Bourliere, M. Bruha, R. Bugianesi, E. Burra, P. Buti, M. Byrne, C.D. Calleja, J.L. Carrieri, P. Carter, F. Fernandez, M.I.C. Castillo-Lopez, G. Castro-Narro, G.E. Chan, H.L.Y. Chan, W.-K. Chang, Y. Colombo, M. Coppell, K.J. Corey, K. Craxi, A. Cryer, D. Dassanayake, A. Martins, A.A.S. de Ledinghen, V. DelPrato, S. Demaio, A. Desalegn, H. Dillon, J. Duseja, A. Dorairaj, P. Ekstedt, M. El Kassas, M. Elsanousi, O.M. Esmat, G. Fan, J.-G. Farpour-Lambert, N. Flisiak, R. Fouad, Y. Fuchs, M. Gani, R.A. Gerber, L. Ghazinyan, H. Gheorghe, L. Goh, G.B.-B. Grønbæk, H. Gulnara, A. Hamid, S. Hebditch, V. Hickman, I.J. Hocking, S.L. Hunyady, B. Idilman, R. Isakov, V.A. Jamal, M.H. Jepsen, P. Iskandar, N.J. Song, M.J. Sudhamshu, K.C. Kakizaki, S. Kalamitsis, G. Kanwal, F. Kao, J.-H. Kaplan, L. Kawaguchi, T. Khader, Y. Kim, S.U. Kodjoh, N. Koek, G. Koike, K. Komas, N.P. Korenjak, M. Kugelmas, M. Labidi, A. Lange, N.F. Lavine, J.E. Lazo, M. Lee, N. Lesmana, C.R.A. Liu, C.-J. Long, M.T. Lopez-Jaramillo, P. Malekzadeh, R. Mahtab, M.A. Marchesini, G. Marinho, R. Vázquez, S.E.M. Mateva, L. Nlombi, C.M. Melin, P. Mikolasevic, I. Milovanovic, T. Musso, C. Nakajima, A. Nava, E. Nersesov, A.V. Nikolova, D. Norris, S. Novak, K. Oben, J. Ong, J.P. Onyekwere, C. Papatheodoridis, G. Paruk, I. Patel, K. Macedo, M.P. Penha-Gonçalves, C. Figueroa, M.P. Hofmann, W.P. Petta, S. de Oliveira, C.P.M.S. Puri, P. Pan, C.Q. Rac, M. Ralston, J. Ramji, A. Razavi, H. Alvares-da-Silva, M.R. Roberts, S. Roden, M. Rose, T. Rouabhia, S. Rovere-Querini, P. Rowe, I.A. Sadirova, S. Salupere, R. Saparbu, T. Sayegh, R. Sebastiani, G. Seki, Y. Selmo, J. Serme, A.K. Shaw, J.E. Shenoy, T. Sheron, N. Shibolet, O. Silva, M. Skrypnyk, I. Socha, P. Soriano, J. Spearman, C.W. Sridharan, K. Suárez, J.J. Sheriff, D.S. Sung, K.-C. Swain, M. Tacke, F. Taheri, S. Tan, S.-S. Tapper, E.B. Yki-Järvinen, H. Thiele, M. Shawa, I.T. Tolmane, I. Torres, E.A. Trauner, M. Treeprasertsuk, S. Turcanu, A. Valantinas, J. Vesterhus, M. Waked, I. Wild, S.H. Willemse, J. Wong, R.J. Xanthakos, S. Young, D.Y. Yu, M.-L. Zheng, K.I. Zeybel, M. Zheng, M.-H. the NAFLD Consensus Consortium
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cebe53fe78dec318608865e58dcc8262
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3100604
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje